Εμφανίζονται 1 - 20 Αποτελέσματα από 61 για την αναζήτηση '"внутрипеченочный холестаз"', χρόνος αναζήτησης: 0,69δλ Περιορισμός αποτελεσμάτων
  1. 1
    Academic Journal

    Συγγραφείς: Zaytsev, I.A.

    Πηγή: ACTUAL INFECTOLOGY; Том 5, № 4 (2017); 160-165
    Актуальная инфектология-Aktualʹnaâ Infektologiâ; Том 5, № 4 (2017); 160-165
    Актуальна інфектологія-Aktualʹnaâ Infektologiâ; Том 5, № 4 (2017); 160-165

    Περιγραφή αρχείου: application/pdf

  2. 2
    Academic Journal

    Πηγή: Transplantologiya. The Russian Journal of Transplantation; Том 16, № 4 (2024); 473-482 ; Трансплантология; Том 16, № 4 (2024); 473-482 ; 2542-0909 ; 2074-0506

    Περιγραφή αρχείου: application/pdf

    Relation: https://www.jtransplantologiya.ru/jour/article/view/940/907; https://www.jtransplantologiya.ru/jour/article/view/940/916; Cawich SO, Sinanan A, Deshpande RR, Gardner MT, Pearce NW, Naraynsingh V. Anatomic variations of the intra-hepatic biliary tree in the Caribbean: a systematic review. World J Gastrointest Endosc. 2021;13(6):170–183. PMID: 34163564 https://doi.org/10.4253/wjge.v13.i6.170; Sticova E, Jirsa M, Pawłowska J. New insights in genetic cholestasis: from molecular mechanisms to clinical implications. Can J Gastroenterol Hepatol. 2018;26;2018:2313675. PMID: 30148122 https://doi.org/10.1155/2018/2313675; Davit-Spraul A, Gonzales E, Baussan C, Jacquemin E. Progressive familial intrahepatic cholestasis. Orphanet J Rare Dis. 2009. PMID: 19133130 https://doi.org/10.1186/1750-1172-4-1; Summerskill WH, Walshe JM. Benign recurrent intrahepatic "obstructive" jaundice. Lancet. 1959;2(7105):686– 690. PMID: 13835689 https://doi.org/10.1016/s0140-6736(59)92128-2; Luketic VA, Shiffman ML. Benign recurrent intrahepatic cholestasis. Clin Liver Dis. 1999;3(3):509–528. PMID: 11291237 https://doi.org/10.1016/s10893261(05)70083-0; Folvik G, Hilde O, Helge GO. Benign recurrent intrahepatic cholestasis: review and long-term follow-up of five cases. Scand J Gastroenterol. 2012;47(4):482– 488. PMID: 22229830 https://doi.org/10.3109/00365521.2011.650191; Halawi A, Ibrahim N, Bitar R. Triggers of benign recurrent intrahepatic cholestasis and its pathophysiology: a review of literature. Acta Gastroenterol Belg. 2021;84(3):477–486. PMID: 34599573 https://doi.org/10.51821/84.3.013; Strubbe B, Geerts A, Van Vlierberghe H, Colle I. Progressive familial intrahepatic cholestasis and benign recurrent intrahepatic cholestasis: a review. Acta Gastroenterol Belg. 2012;75(4):405–410. PMID: 23402083; Cai SY, Gautam S, Nguyen T, Soroka CJ, Rahner C, Boyer JL. ATP8B1 deficiency disrupts the bile canalicular membrane bilayer structure in hepatocytes, but FXR expression and activity are maintained. Gastroenterology. 2009;136(3):1060–1069. PMID: 19027009 https://doi.org/10.1053/j.gastro.2008.10.025; Paulusma CC, de Waart DR, Kunne C, Mok KS, Elferink RP. Activity of the bile salt export pump (ABCB11) is critically dependent on canalicular membrane cholesterol content. J Biol Chem. 2009;284(15):9947–9954. PMID: 19228692 https://doi.org/10.1074/jbc.M808667200; Arthur Lorio E, Valadez D, Alkhouri N, Loo N. Cholestasis in benign recurrent intrahepatic cholestasis 2. ACG Case Rep J. 2020;7(6):e00412. PMID: 3264773 https://doi.org/10.14309/crj.0000000000000412; Davit-Spraul A, Gonzales E, Baussan C, Jacquemin E. Progres sive familial intrahepatic cholestasis. Orphanet J Rare Dis. 2009;4:1. PMID: 19133130 https://doi.org/10.1186/17501172-4-1; van der Woerd WL, van Mil SW, Stapelbroek JM, Klomp LW, van de Graaf SF, Houwen RH. Familial cholestasis: progressive familial intrahepatic cholestasis, benign recurrent intrahepatic cholestasis and intrahepatic cholestasis of pregnancy. Best Pract Res Clin Gastroenterol. 2010;24(5):541–553. PMID: 20955958 https://doi.org/10.1016/j.bpg.2010.07.010; Dietrich CG, Geier A. Effect of drug transporter pharmacogenetics on cholestasis. Expert Opin Drug Metab Toxicol. 2014;10(11):1533–1551. PMID: 25260651 https://doi.org/10.1517/17425255.2014.963553; Ermis F, Oncu K, Ozel M, Yazgan Y, Gurbuz AK, Demirturk L, et al. Benign recurrent intrahepatic cholestasis: late initial diagnosis in adulthood. Ann Hepatol. 2010;9(2):207–210. PMID: 20526019; European Association for the Study of the Liver. EASL Clinical Practice Guidelines: management of cholestatic liver diseases. J Hepatol. 2009;51(2):237– 267. PMID: 19501929 https://doi.org/10.1016/j.jhep.2009.04.009; Suzuki H, Arinaga-Hino T, Sano T, Mihara Y, Kusano H, Mizuochi T, et al. Case report: a rare case of benign recurrent intrahepatic cholestasis-type 1 with a novel heterozygous pathogenic variant of ATP8B1. Front Med (Lausanne). 2022;9:891659. PMID: 35572954 https://doi.org/10.3389/fmed.2022.891659; Prince MI, Burt AD, Jones DE. Hepatitis and liver dysfunction with rifampicin therapy for pruritus in primary biliary cirrhosis. Gut. 2002;50(3):436– 439. PMID: 11839728 https://doi.org/10.1136/gut.50.3.436; Helgadottir H, Folvik G, Vesterhus M. Improvement of cholestatic episodes in patients with benign recurrent intrahepatic cholestasis (BRIC) treated with rifampicin. A long-term follow-up. Scand J Gastroenterol. 2023;58(5):512–520. PMID: 36369734 https://doi.org/10.1080/00365521.2022.2143725; Kumagi T, Heathcote EJ. Successfully treated intractable pruritus with rifampin in a case of benign recurrent intrahepatic cholestasis. Clin J Gastroenterol. 2008;1(4):160–163. PMID: 26193696 https://doi.org/10.1007/s12328-0080027-y; Schoeneich K, Frimmel S, Koball S. Successful treatment of a patient with benign recurrent intrahepatic cholestasis type 1 with albumin dialysis. Artif Organs. 2020;44(3):341–342. PMID: 31642075 https://doi.org/10.1111/aor.13572; Stapelbroek JM, van Erpe cum KJ, Klomp LW, Venneman NG, Schwartz TP, van Berge Henegouwen GP, et al. Nasobiliary drainage induces long-lasting remission in benign recurrent intrahepatic cholestasis. Hepatology. 2006;43(1):51–53. PMID: 16374853 https://doi.org/10.1002/hep.20998; Choudhury A, Kulkarni AV, Sahoo B, Bihari C. Endoscopic nasobiliary drainage: an effective treatment option for benign recurrent intrahe patic cholestasis (BRIC). BMJ Case Rep. 2017;2017:bcr2016218874. PMID: 28476903 https://doi.org/10.1136/bcr2016-218874; Mezey E, Burns C, Burdick JF, Braine HG. A case of severe benign intrahepatic cholestasis treated with liver transplantation. Am J Gastroenterol. 2002;97(2):475–477. PMID: 11866291 https://doi.org/10.1111/j.15720241.2002.05458.x; https://www.jtransplantologiya.ru/jour/article/view/940

  3. 3
  4. 4
    Academic Journal

    Συγγραφείς: Pinsky, L.L.

    Πηγή: Aktualʹnaâ Infektologiâ, Vol 8, Iss 3-4, Pp 20-28 (2020)
    Актуальна інфектологія-Aktualʹnaâ Infektologiâ; Том 8, № 3-4 (2020); 20-28
    Актуальная инфектология-Aktualʹnaâ Infektologiâ; Том 8, № 3-4 (2020); 20-28
    ACTUAL INFECTOLOGY; Том 8, № 3-4 (2020); 20-28

    Περιγραφή αρχείου: application/pdf

  5. 5
  6. 6
  7. 7
  8. 8
    Academic Journal
  9. 9
    Academic Journal

    Συγγραφείς: Ebaye Nsan Ekom Nsed, Boichuk, O. H.

    Πηγή: Achievements of Clinical and Experimental Medicine; No. 1 (2020); 83-88 ; Достижения клинической и экспериментальной медицины; № 1 (2020); 83-88 ; Здобутки клінічної і експериментальної медицини; № 1 (2020); 83-88 ; 2415-8836 ; 1811-2471 ; 10.11603/1811-2471.2020.v.i1

    Περιγραφή αρχείου: application/pdf

  10. 10
    Academic Journal
  11. 11
    Academic Journal

    Πηγή: Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics); Том 65, № 2 (2020); 108-116 ; Российский вестник перинатологии и педиатрии; Том 65, № 2 (2020); 108-116 ; 2500-2228 ; 1027-4065 ; 10.21508/1027-4065-2020-65-2

    Περιγραφή αρχείου: application/pdf

    Relation: https://www.ped-perinatology.ru/jour/article/view/1118/924; Kamath B.M., Loomes K.M., Piccoli D.A. Medical management of Alagille syndrome. J Pediatr Gastroenterol Nutr 2010; 50(6): 580–586. DOI:10.1097/MPG.0b013e3181d98ea8; Lykavieris P., Hadchouel M., Chardot C., Bernard O. Outcome of liver disease in children with Alagille syndrome: a study of 163 patients. Gut 2001; 49(3): 431–435. DOI:10.1136/gut.49.3.431; Li L., Krantz I.D., Deng Y., Genin A., Banta A.B., Collins C.C. et al. Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1. Nat Genet 1997; 16 (3): 243–251. DOI:10.1038/ng0797-243; Oda T., Elkahloun A.G., Pike B.L., Okajima K., Krantz I.D., Genin A. et al. Mutations in the human Jagged1 gene are responsible for Alagille syndrome. Nat Genet 1997; 16(3): 235– 242. DOI:10.1038/ng0797-235; McDaniell R., Warthen D.M., Sanchez-Lara P.A., Pai A., Krantz I.D., Piccoli D.A. et al. NOTCH2 mutations cause Alagille syndrome, a heterogeneous disorder of the notch signaling pathway. Am J Hum Genet 2006; 79(1): 169–173. DOI:10.1086/505332; Hofmann J.J., Zovein A.C., Koh H., Radtke F., Weinmaster G., Iruela-Arispe M.L. Jagged1 in the portal vein mesenchyme regulates intrahepatic bile duct development: insights into Alagille syndrome. Development 2010; 137(23): 4061–4072. DOI:10.1242/dev.052118; Turnpenny P.D., Ellard S. Alagille syndrome: pathogenesis, diagnosis and management. Eur J Hum Genet 2012; 20(3): 251–257. DOI:10.1038/ejhg.2011.181; Mitchell E., Gilbert M., Loomes K.M. Alagille Syndrome. Clin Liver Dis 2018; 22(4): 625–641. DOI:10.1016/j.cld.2018.06.001; Tsai E.A., Gilbert M.A., Grochowski C.M., Underkoffler L.A., Meng H., Zhang X. et al. THBS2 Is a Candidate Modifier of Liver Disease Severity in Alagille Syndrome. Cell Mol Gastroenterol Hepatol 2016; 2(5): 663–675.e2. DOI:10.1016/j.jcmgh.2016.05.013; Hofmann J.J., Briot A., Enciso J., Zovein A.C., Ren S., Zhang Z.W. et al. Endothelial deletion of murine Jag1 leads to valve calcification and congenital heart defects associated with Alagille syndrome. Development 2012; 139(23): 4449– 4460. DOI:10.1242/dev.084871; Vajro P., Ferrante L., Paolella G. Alagille syndrome: an overview. Clin Res Hepatol Gastroenterol 2012; 36(3): 275–277. DOI:10.1016/j.clinre.2012.03.019; De Bruyne R., Van Biervliet S., Vande Velde S., Van Winckel M. Clinical practice: neonatal cholestasis. Eur J Pediatr 2011; 170(3): 279–284. DOI:10.1007/s00431-010-1363-8; Kamath B.M., Schwarz K.B., Hadzić N. Alagille syndrome and liver transplantation. J Pediatr Gastroenterol Nutr 2010;50 (1): 11–5. DOI:10.1097/MPG.0b013e3181c1601f; Kamath B.M., Loomes K.M., Oakey R.J., Emerick K.E., Conversano T., Spinner N.B. et al. Facial features in Alagille syndrome: specific or cholestasis facies? Am J Med Genet 2002; 112(2): 163–170. DOI:10.1002/ajmg.10579; Cho H.L., Kim J.S., Paeng S.S., Lee S.H. Butterfly vertebra with lumbar intervertebral disc herniation. J Neurosurg Spine 2011; 15(5): 567–570. DOI:10.3171/2011.6.SPINE1178; Subramaniam P., Knisely A., Portmann B., Qureshi S.A., Aclimandos W.A., Karani J.B. et al. Diagnosis of Alagille syndrome – 25 years of experience at King’s College Hospital. J Pediatr Gastroenterol Nutr 2011; 52(1): 84–89. DOI:10.1097/MPG.0b013e3181f1572d; Mainwaring R.D., Sheikh A.Y., Punn R., Reddy V.M., Hanley F.L. Surgical outcomes for patients with pulmonary atresia/major aortopulmonary collaterals and Alagille syndrome. Eur J Cardiothorac Surg 2012; 42(2): 235–240; discussion 240–241. DOI:10.1093/ejcts/ezr310; Kamath B.M., Yin W., Miller H., Anand R., Rand E.B., Alonso E. et al. Outcomes of liver transplantation for patients with Alagille syndrome: the studies of pediatric liver transplantation experience. Liver Transpl 2012; 18(8): 940–948. DOI:10.1002/lt.23437; Spinner N.B., Leonard L.D., Krantz I.D. Alagille Syndrome. In: Adam M.P., Ardinger H.H., Pagon R.A., Wallace S.E., Bean L.J.H., Stephens K., Amemiya A., editors. SourceGeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993–2019. PMID: 20301450.; Волынец Г.В., Хавкин А.И., Никитин А.В., Скворцова Т.А. Дифференциальная диагностика и принципы терапии врожденных холестатических болезней у детей раннего возраста. Монография. М.: Прима Принт, 2018; 160. [Volynets G.V., Khavkin A.I., Nikitin A.V., Skvortsova T.A. Differential diagnosis and treatment principles of congenital cholestatic diseases in young children. Monography. Moscow: Prima Print, 2018; 160. (in Russ.)]

  12. 12
    Academic Journal

    Συγγραφείς: Cemortan, Maria

    Πηγή: Bulletin of the Academy of Sciences of Moldova. Medical Sciences; Vol. 66 No. 2 (2020): Medical Sciences; 155-161 ; Buletinul Academiei de Științe a Moldovei. Științe medicale; Vol. 66 Nr. 2 (2020): Ştiinţe medicale; 155-161 ; Вестник Академии Наук Молдовы. Медицина; Том 66 № 2 (2020): Медицина; 155-161 ; 1857-0011

    Περιγραφή αρχείου: application/pdf

    Διαθεσιμότητα: https://bulmed.md/bulmed/article/view/3234

  13. 13
  14. 14
    Academic Journal
  15. 15
  16. 16
    Academic Journal

    Relation: Бик-Мухаметова, Я. И. Анамнестические и биохимические предикторы акушерских и перинатальных осложнений при внутрипеченочном холестазе беременных / Я. И. Бик-Мухаметова, Т. Н. Захаренкова // Проблемы здоровья и экологии. – 2022. – Т. 19, № 2. – С. 48–56.; http://elib.gsmu.by/handle/GomSMU/11859; https://doi.org/10.51523/2708-6011.2022-19-2-06

  17. 17
  18. 18
  19. 19
  20. 20